Watson Laboratories, Inc.
Quick facts
Phase 3 pipeline
- Clindamycin Phosphate / Benzoyl Peroxide Gel · Dermatology
Clindamycin reduces acne-causing bacteria while benzoyl peroxide provides antimicrobial and keratolytic effects to treat acne vulgaris.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Watson Laboratories, Inc.
What is Watson Laboratories, Inc.'s pipeline?
Watson Laboratories, Inc. has 1 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Clindamycin Phosphate / Benzoyl Peroxide Gel.
Related
- Sector hub: All tracked pharma companies